The impact of body mass index on survival in stage 3 and 4 lung cancer.
Kit Man Wong
No relevant relationships to disclose
Sinead Cuffe
No relevant relationships to disclose
Linda E. Coate
No relevant relationships to disclose
Osvaldo Espin-Garcia
No relevant relationships to disclose
Kevin Boyd
No relevant relationships to disclose
Ronald Feld
No relevant relationships to disclose
Natasha B. Leighl
No relevant relationships to disclose
Frances A. Shepherd
Consultant or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Recombio; Roche
Stock Ownership - Lilly; Pfizer
Honoraria - GlaxoSmithKline; Lilly; Roche
Expert Testimony - AstraZeneca
Wei Xu
No relevant relationships to disclose
Geoffrey Liu
No relevant relationships to disclose